EPO and chronic kidney disease: As shown in Figure 2, the pathophysiology of CKD involves the progressive reduction in EPO production, the reduced bone marrow response to EPO stimuli (due to uremic toxins and erythropoiesis-suppressing cytokines), and the decreased erythrocyte half-life.